|本期目录/Table of Contents|

[1]王玉婷,刘亚军,任婧婧,等.羊膜腔穿刺术对HBV 携带孕妇胎儿宫内感染风险的研究[J].传染病信息,2019,04:355-358.
 WANG Yu-ting,LIU Ya-jun,REN Jing-jing,et al.Risk of intrauterine fetal infection in pregnant women with HBV by amniocentesis[J].Infectious Disease Information,2019,04:355-358.
点击复制

羊膜腔穿刺术对HBV 携带孕妇胎儿宫内感染风险的研究(PDF)

《传染病信息》[ISSN:1007-8134/CN:11-3886/R]

期数:
2019年04期
页码:
355-358
栏目:
论著
出版日期:
2019-09-12

文章信息/Info

Title:
Risk of intrauterine fetal infection in pregnant women with HBV by amniocentesis
文章编号:
 1007-8134(2019)04-0355-04
作者:
王玉婷刘亚军任婧婧孙 越张 蔼
266011,青岛市出生缺陷综合防治中心(王玉婷、孙越、张蔼);266011,青岛市妇女儿童医院产科(王玉婷、任婧婧、孙越、张蔼);266555,青岛大学附属医院产科(刘亚军)
Author(s):
WANG Yu-ting LIU Ya-jun REN Jing-jing SUN Yue ZHANG Ai*
Qingdao Birth Defect and Prevention Center, 266011, China Department of Obstetrics, Qingdao Women and Children’s Hospital, 266011, China
*Corresponding author, E-mail: aizhangtj@126.com
关键词:
 HBV 携带羊膜腔穿刺术宫内感染产前诊断
Keywords:
HBV carrier amniocentesis intrauterine infection prenatal diagnosis
分类号:
 R714.55 
DOI:
10.3969/j.issn.1007-8134.2019.04.019
文献标识码:
A
摘要:
目的 探讨羊膜腔穿刺术对HBV 携带孕妇胎儿宫内感染风险的影响,为产前诊断提供科学指导。方法 选取 2015 年1 月—2019 年1 月就诊于青岛市妇女儿童医院的504 例HBV 携带孕妇作为研究对象,其中,将126 例行羊膜腔穿 刺术的孕妇设为观察组,其余未行羊膜腔穿刺术的378 例孕妇设为对照组。对比分析不同HBeAg 携带状态、HBV DNA 载 量、穿刺术中出血状况、操作者资质和经验下观察组与对照组胎儿宫内感染的发生情况。结果 504 例HBV 携带孕妇中胎 儿宫内感染的总发生率为4.17%(21/504),其中,观察组感染率为7.14%(9/126),对照组感染率为3.17%(12/378); 在HBeAg(+)与HBV DNA > 1.0×107 cps/ml 2 种情况下,观察组胎儿宫内感染发生率分别为15.38%(6/39)、70.00% (7/10),均显著高于对照组(P 均< 0.05);在HBeAg(-)与HBV DNA 为l.0×103 ~ 1.0×107 cps/ml 情况下,观察组和 对照组胎儿宫内感染发生率差异均无统计学意义(P 均> 0.05)。此外,穿刺出血情况、操作者资质和经验、分娩方式等对 羊膜腔穿刺术后胎儿宫内感染发生率的影响差异均无统计学意义(P 均> 0.05)。Logistic 回归分析显示,HBeAg(+)、 HBV DNA 载量> 1.0×107 cps/ml、羊膜腔穿刺术是HBV 携带孕妇胎儿宫内感染的危险因素。结论 HBeAg(+)、 HBV DNA 载量> 1.0×107 cps/ml、羊膜腔穿刺术是HBV 携带孕妇胎儿宫内感染的危险因素。当HBV 携带孕妇的 HBeAg(+)、HBV DNA > 1.0×107 cps/ml 时,羊膜腔穿刺术可能增加胎儿宫内感染的风险。HBV 携带孕妇需要在产 前诊断前对HBeAg 状况和HBV DNA 载量进行评估,以决定是否行羊膜腔穿刺术。
Abstract:
Objective To explore the effect of amniocentesis on the risk of intrauterine fetal infection in pregnant women with HBV and provide scientific guidance for prenatal diagnosis. Methods A total of 504 pregnant women with HBV admitted in Qingdao Women and Children’s Hospital from January 2015 to January 2019 were included in the study. One hundred and twenty-six pregnant women who underwent amniocentesis were allocated in the observation group and the other 378 pregnant women without amniocentesis were taken as the control group. At different expression levels of HBeAg, load of HBV DNA, bleeding amount during puncture, qualifications and experience of operators, the intrauterine fetal infection rates between 2 groups were compared. Results The total incidence of intrauterine fetal infection in 504 pregnant women with HBV was 4.17% (21/504), that in observation group was 7.14% (9/126) and that in the control group was 3.17% (12/378). When HBeAg(+) and HBV DNA > 1.0×107 cps/ml co-existed, the incidence of intrauterine fetal infection in the observation group was 15.38% (6/39) and 70.00% (7/10) respectively, which were significantly higher than that in the control group (P < 0.0.5). When HBeAg(-) and HBV DNA between l.0×103 cps/ml and 1.0×107 cps/ml co-existed, the incidence of intrauterine fetal infection between 2 groups showed no significant difference (P> 0.05). In addition, the incidence of fetal intrauterine infection after amniocentesis had no significant difference among puncture bleeding, doctors’s experience and delivery mode (P > 0.05). Logistic regression analysis showed that HBeAg(+), HBV DNA load> 1.0×107 cps/ml and amniocentesis were risk factors for intrauterine infection in pregnant women with HBV. Conclusions HBeAg, HBV DNA load > 1.0×107 cps/ml and amniocentesis are risk factors for intrauterine infection in pregnant women with HBV. When HBeAg(+) and HBV DNA> 1.0×107 cps/ml co-exist in pregnant women with HBV, amniocentesis may increase the risk of intrauterine fetal infection. HBeAg status and HBV DNA load in pregnant women with HBV should be evaluated before prenatal diagnosis to determine whether amniocentesis is performed.     

参考文献/References


[1] Musilova I, Bestvina T, Stranik J, et al. Transabdominal amniocentesis is a feasible and safe procedure in preterm prelabor repture of membranes[J]. Fetal Diagn Ther, 2017, 42(4):257- 261.
[2] Cobo T, Kacerovsky M, Jacobsson B. Noninvasive sampling of the intrauterine environment in women with preterm labor and intact membranes[J]. Fetal Diagn Ther, 2018, 43(4):241-249.
[3] Tanimura K, Yamada H. Maternal and neonatal screening methods for congenital cytomegalovirus infection[J]. J Obstet Gynaecol Res, 2019, 45(3):514-521.
[4] 中国肝炎防治基金会,中华医学会感染病学分会,中华医学 会肝病学分会. 乙型肝炎母婴阻断临床管理流程[J]. 临床 肝胆病杂志,2017,33(7):1214-1217.
[5] 熊英. 乙型肝炎病毒敏感性指标检测的临床意义[J]. 中华 医院感染学杂志,2011,21(14):2962-2964.
[6] Chen S, Li J, Wang D, et al. The hepatitis B epidemic in China should receive more attention[J]. Lancet, 2018, 391(10130):1572.
[7] 王亚东. 乙型肝炎孕妇HBV 血清标志物与HBV DNA 载量及 ALT 的相关性分析[J]. 传染病信息,2019,32(3):233-235.
[8] 刘义庆,李丽,孙文萍,等. 山东地区孕妇乙型肝炎感染和 免疫状况分析[J]. 中国卫生检验杂志,2017,27(7):1029- 1031.
[9] 黄海燕,王淼,周建华. 不同孕期抗病毒治疗对高HBV-DNA 病毒载量孕母婴传播阻断免疫效率的影响[J]. 中国优生与 遗传杂志,2016,24(11):72-73.
[10] 刘玉娟,蔡秋娥,王淼,等. 抗病毒治疗在阻断高病毒载量 乙肝孕妇母婴传播中的临床效果[J]. 广东医学,2018, 39(1):2483-2484,2487.
[11] 谭静,叶晓林,王慧. 妊娠中晚期应用替比夫定阻断HBsAg 阳性孕妇HBV 母婴传播效果及对婴儿接种乙肝疫苗应答的影 响[J]. 实用肝脏病杂志,2019,22(1):49-52.
[12] Bai H, Zhang L, Ma L, et al. Relationship of hepatitis B virus infection of placental barrier and hepatitis B virus intra-uterine transmission mechanism[J]. World J Gastroentero, 2007, 13(26):3625-3630.
[13] 中华医学会妇产科学分会妊娠期高血压疾病学组. 高龄妇女 妊娠前、妊娠期及分娩期管理专家共识[J]. 中华妇产科杂志, 2019,54(1):24-26.
[14] 熊盈,饶腾子,王萍,等. 乙肝孕妇介入性产前诊断的现状 分析[J]. 中国产前诊断杂志(电子版),2018,10(3):1-4.
[15] Davies G, Wilson RD, Désilets V, et al. Amniocentesis and women with hepatitis B, hepatitis C, or human immunodeficiency virus[J]. J Obstet Gynaecol Can, 2003, 25(2):145-152.
[16] 黎丽芬,陈丽莉. 乙型肝炎病毒携带孕妇羊膜腔穿刺术后胎 儿宫内感染风险分析[J]. 深圳中西医结合杂志,2017, 27(9):44-45.
[17] Yi W, Pan CQ, Hao J, et al. Risk of vertical transmission of Hepatitis B after amniocentesis in HBs antigen-positive mothers [J]. J Hepatol, 2014, 60(3):523-529.
[18] 陈映婷,潘丽,苏文. 乙肝病毒携带孕妇羊膜腔穿刺术后胎 儿宫内感染的风险[J]. 妇产与遗传(电子版),2014, 4(2):36-40.
[19] 陈萍,段灵,李正峰. HBV 孕妇新生儿宫内感染的影响因素 研究[J]. 中华医院感染学杂志,2018,28(16):2446-2449.

备注/Memo

备注/Memo:
[ 基金项目] 青岛市医药科研指导计划(2018-WJZD096);青岛市医疗卫生优秀人才培养项目(YQR-2017069)
[ 通信作者] 张蔼,E-mail: aizhangtj@126.com
更新日期/Last Update: 2019-09-15